PMC:7289100 / 41292-42777 12 Projects
Annnotations
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T557 | 0-4 | PR:000001393 | denotes | IL-6 |
| T21859 | 0-4 | PR:000001393 | denotes | IL-6 |
| T558 | 96-107 | CL:0000542 | denotes | lymphocytes |
| T19136 | 96-107 | CL:0000542 | denotes | lymphocytes |
| T559 | 109-118 | CL:0000576 | denotes | monocytes |
| T28167 | 109-118 | CL:0000576 | denotes | monocytes |
| T560 | 124-135 | CL:0000057 | denotes | fibroblasts |
| T98906 | 124-135 | CL:0000057 | denotes | fibroblasts |
| T561 | 162-170 | SP_10 | denotes | SARS-CoV |
| T25741 | 162-170 | SP_10 | denotes | SARS-CoV |
| T562 | 210-214 | PR:000001393 | denotes | IL-6 |
| T11441 | 210-214 | PR:000001393 | denotes | IL-6 |
| T563 | 220-240 | UBERON:0002031;CL:0002328 | denotes | bronchial epithelial |
| T67653 | 220-240 | UBERON:0002031;CL:0002328 | denotes | bronchial epithelial |
| T564 | 241-246 | CL:0002328 | denotes | cells |
| T73773 | 241-246 | CL:0002328 | denotes | cells |
| T565 | 262-266 | PR:000001393 | denotes | IL-6 |
| T15981 | 262-266 | PR:000001393 | denotes | IL-6 |
| T566 | 370-380 | SP_7 | denotes | SARS-CoV-2 |
| T39306 | 370-380 | SP_7 | denotes | SARS-CoV-2 |
| T567 | 392-400 | SP_7 | denotes | COVID-19 |
| T89461 | 392-400 | SP_7 | denotes | COVID-19 |
| T568 | 446-457 | UBERON:0001004 | denotes | respiratory |
| T69527 | 446-457 | UBERON:0001004 | denotes | respiratory |
| T569 | 537-542 | UBERON:0000178 | denotes | blood |
| T63239 | 537-542 | UBERON:0000178 | denotes | blood |
| T570 | 553-557 | PR:000001393 | denotes | IL-6 |
| T30193 | 553-557 | PR:000001393 | denotes | IL-6 |
| T571 | 559-577 | PR:000005897 | denotes | C-reactive protein |
| T46291 | 559-577 | PR:000005897 | denotes | C-reactive protein |
| T572 | 579-582 | PR:000005897 | denotes | CRP |
| T28455 | 579-582 | PR:000005897 | denotes | CRP |
| T573 | 691-695 | PR:000001393 | denotes | IL-6 |
| T70338 | 691-695 | PR:000001393 | denotes | IL-6 |
| T574 | 812-823 | DG_35 | denotes | tocilizumab |
| T60533 | 812-823 | DG_35 | denotes | tocilizumab |
| T575 | 910-918 | SP_7 | denotes | Covid-19 |
| T64207 | 910-918 | SP_7 | denotes | Covid-19 |
| T576 | 955-966 | DG_35 | denotes | tocilizumab |
| T25449 | 955-966 | DG_35 | denotes | tocilizumab |
| T577 | 1088-1093 | UBERON:0000170 | denotes | lungs |
| T54606 | 1088-1093 | UBERON:0000170 | denotes | lungs |
| T578 | 1255-1266 | DG_35 | denotes | tocilizumab |
| T83703 | 1255-1266 | DG_35 | denotes | tocilizumab |
| T579 | 1404-1415 | DG_35 | denotes | tocilizumab |
| T67676 | 1404-1415 | DG_35 | denotes | tocilizumab |
| T580 | 1420-1429 | DG_39 | denotes | sarilumab |
| T51113 | 1420-1429 | DG_39 | denotes | sarilumab |
| T581 | 1445-1455 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T28736 | 1445-1455 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T582 | 1459-1470 | DG_41 | denotes | baricitinib |
| T15613 | 1459-1470 | DG_41 | denotes | baricitinib |